Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers

Clinical trial NCT04083170 · TERMINATED

Trial details

NCT number: NCT04083170
Sponsor: Fred Hutchinson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Erythroid Leukemia Acute Lymphoblastic Leukemia Acute Megakaryoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm HIV Infection Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Non-Hodgkin Lymphoma Refractory Anemia

Start date: 2022-10-06
Primary completion: 2022-11-11
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.